SCOPE FLUIDICS SA ZY-10 Market Cap ($94.51 Million)
Market Cap & Net Worth: SCOPE FLUIDICS SA ZY-10 (S84)
SCOPE FLUIDICS SA ZY-10 market cap. SCOPE FLUIDICS SA ZY-10 (F:S84) has a market capitalization of $94.51 Million (€80.84 Million) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #19271 globally and #1769 in its home market, demonstrating a 10.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCOPE FLUIDICS SA ZY-10's stock price €28.80 by its total outstanding shares 3168271 (3.17 Million).
SCOPE FLUIDICS SA ZY-10 Market Cap History (2021–2026)
SCOPE FLUIDICS SA ZY-10 market cap history from 2021 to 2026. Data shows growth from $107.79 Million to $106.68 Million (0.98% CAGR). Check S84 stock price for real-time trading data and today's change.
SCOPE FLUIDICS SA ZY-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCOPE FLUIDICS SA ZY-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see SCOPE FLUIDICS SA ZY-10 (S84) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
1387.16x
SCOPE FLUIDICS SA ZY-10's market cap is 1387.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $150.75 Million | $404.00K | $318.49 Million | 373.15x | 0.47x |
| 2023 | $153.72 Million | $516.00K | -$18.79 Million | 297.90x | N/A |
| 2024 | $157.98 Million | $131.00K | $65.42 Million | 1205.93x | 2.41x |
| 2025 | $138.72 Million | $100.00K | -$46.36 Million | 1387.16x | N/A |
Competitor Companies of S84 by Market Capitalization
Companies near SCOPE FLUIDICS SA ZY-10 in the global market cap rankings as of October 31, 2026. See SCOPE FLUIDICS SA ZY-10 balance sheet independence to understand what proportion of total assets are financed by equity.
Key companies related to SCOPE FLUIDICS SA ZY-10 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #136 globally with a market cap of $167.39 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #525 globally with a market cap of $51.71 Billion USD ( CN¥353.41 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $709.18 |
| #136 | Danaher Corporation | NYSE:DHR | $167.39 Billion | $236.98 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $436.00 |
| #525 | WuXi AppTec Co Ltd | SHG:603259 | $51.71 Billion | CN¥142.89 |
Market Capitalization of SCOPE FLUIDICS SA ZY-10 (2021–2026)
Market capitalization of SCOPE FLUIDICS SA ZY-10 from 2021 to today. Between 2021 and today, SCOPE FLUIDICS SA ZY-10's market cap moved from $107.79 Million to $ 106.68 Million, with a yearly change of 0.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €106.68 Million | -23.10% |
| 2025 | €138.72 Million | -12.19% |
| 2024 | €157.98 Million | +2.77% |
| 2023 | €153.72 Million | +1.97% |
| 2022 | €150.75 Million | +39.86% |
| 2021 | €107.79 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of SCOPE FLUIDICS SA ZY-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.51 Million USD |
| MoneyControl | $94.51 Million USD |
| MarketWatch | $94.51 Million USD |
| marketcap.company | $94.51 Million USD |
| Reuters | $94.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.